advertisement
Aihara M 83
Showing records 1 to 25 | Display all abstracts from Aihara M106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Sakata R
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Liu M
Biomolecules 2022; 12:
106553 Genetic variants associated with glaucomatous visual field loss in primary open-angle glaucoma
Mabuchi F
Scientific reports 2022; 12: 20744
106082 Recent Trends in Treatment and Associated Costs of Primary Angle-Closure Glaucoma: A Retrospective Cohort Study
Fujita A
Ophthalmology. Glaucoma 2023; 6: 308-315
106908 Validity of Algorithms to Identify Patients with Glaucoma Using the Japanese Claims Data
Fujita A
Journal of Glaucoma 2023; 32: 307-312
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Zhang X
Ophthalmology 2023; 130: 111-119
105763 METTL23 mutation alters histone H3R17 methylation in normal-tension glaucoma
Pan Y
Journal of Clinical Investigation 2022; 132:
106411 Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials
Tanihara H
American Journal of Ophthalmology 2022; 248: 35-44
106553 Genetic variants associated with glaucomatous visual field loss in primary open-angle glaucoma
Mabuchi N
Scientific reports 2022; 12: 20744
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Guo PY
Ophthalmology 2023; 130: 111-119
106908 Validity of Algorithms to Identify Patients with Glaucoma Using the Japanese Claims Data
Aoyama Y
Journal of Glaucoma 2023; 32: 307-312
106411 Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials
Yamamoto T
American Journal of Ophthalmology 2022; 248: 35-44
105763 METTL23 mutation alters histone H3R17 methylation in normal-tension glaucoma
Suga A
Journal of Clinical Investigation 2022; 132:
105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Honjo M
Biomolecules 2022; 12:
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Fujishiro T
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106082 Recent Trends in Treatment and Associated Costs of Primary Angle-Closure Glaucoma: A Retrospective Cohort Study
Hashimoto Y
Ophthalmology. Glaucoma 2023; 6: 308-315
106908 Validity of Algorithms to Identify Patients with Glaucoma Using the Japanese Claims Data
Yamana H
Journal of Glaucoma 2023; 32: 307-312
105839 Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor
Yamagishi R
Biomolecules 2022; 12:
106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Lin C
Ophthalmology 2023; 130: 111-119
106082 Recent Trends in Treatment and Associated Costs of Primary Angle-Closure Glaucoma: A Retrospective Cohort Study
Matsui H
Ophthalmology. Glaucoma 2023; 6: 308-315
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Saito H
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
106553 Genetic variants associated with glaucomatous visual field loss in primary open-angle glaucoma
Sakurada Y
Scientific reports 2022; 12: 20744
105763 METTL23 mutation alters histone H3R17 methylation in normal-tension glaucoma
Kimura I
Journal of Clinical Investigation 2022; 132:
106411 Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials
Aihara M
American Journal of Ophthalmology 2022; 248: 35-44
106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Nakamura N
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69
